According to Editas Medicine 's latest financial reports the company's current revenue (TTM) is $78.12 M. In 2022 the company made a revenue of $19.71 M a decrease over the years 2021 revenue that were of $25.54 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $78.12 M | 296.34% |
2022 | $19.71 M | -22.84% |
2021 | $25.54 M | -71.85% |
2020 | $90.73 M | 341.93% |
2019 | $20.53 M | -35.71% |
2018 | $31.93 M | 132.64% |
2017 | $13.72 M | 126.8% |
2016 | $6.05 M | 271.58% |
2015 | $1.62 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Organovo ONVO | $0.24 M | -99.69% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $21.83 M | -72.05% | ๐ฌ๐ง UK |
Novavax NVAX | $0.69 B | 787.65% | ๐บ๐ธ USA |
Novocure
NVCR | $0.50 B | 551.97% | Jersey |